期刊文献+

胺碘酮联用氯沙坦对高血压患者阵发性心房颤动的作用 被引量:1

下载PDF
导出
摘要 目的:探讨胺碘酮联用氯沙坦与高血压患者阵发性心房颤动复律后窦性心律的维持效果及对左房内径的影响。方法:对2003年2月至2007年收治的高血压合并阵发性房颤58例患者随机分成2组,氨氯地平组与氯沙坦组,观察两组患者联用胺碘酮复律后对窦性心律的维持效果。结果:胺碘酮联用氯沙坦对复律后窦性心律的维持及左房内径的作用优氨氯地平组,有统计学意义(P<0.05)。结论:胺碘酮联用氯沙坦对高血压合并阵发性房颤患者转复后窦性心律的维持、减少房颤的复发以及缩小心房内径等方面的作用优于氨氯地平。
作者 王红梅
出处 《山西职工医学院学报》 CAS 2009年第2期41-42,共2页 Journal of Shanxi Medical College for Continuing Education
  • 相关文献

参考文献2

二级参考文献22

  • 1Walraven C,Hart RG,Singer DE,et al. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation An individual patient meta-analysis. JAMA, 2002,288: 2441-2448.
  • 2Go AS,Hylek EM,Chang Y,et al. Anticoagulation therapy for stroke prevention in atrial fibrillation. How well do randomized trials translate into clinical practice? JAMA,2003,290:2685 -2692.
  • 3Wang TJ,Massaro JM,Levy D,et al. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community The Framingham Heart Study.JAMA ,2003,290:1049-1056.
  • 4SPORTIF Ⅲ investigators. Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF Ⅲ): randomized controlled trial. Lancet, 2003, 362: 1691-1698.
  • 5Wattigney WA,Mensah GA,Croft JB. Increasing trends in hospitalization for atrial fibrillation in the united states, 1985 through 1999 implications for primary prevention. Circulation,2003,108 :711-716.
  • 6Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation-Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Lancet, 2000,356:1789-1794.
  • 7Louis A, Cleland JG, Crabbe S, et al. Clinical trials update:CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the scientific sessions of the American College of Cardiology,2001. Eur J Heart Fail ,2001,3:381-387.
  • 8The AFFIRM investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med, 2002,347:1825 - 1833.
  • 9Van Gelder I,Hagens V, Bosker H,et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med ,2002,347:1834-1840.
  • 10The AFFIRM Investigators Relationships Between Sinus Rhythm,Treatment,and Survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM)Study. Circulation ,2004,109:1509-1513.

共引文献45

同被引文献11

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部